REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

C.I. Farmacapsulas S.A.S. (Colombia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: C.I. Farmacapsulas S.A.S. Profile Updated: January 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Farmacapsulas is a global company dedicated to producing hard capsules (empty) and oral pharmaceutical manufacturer (capsules, tablets, suspensions, etc..). The company currently distributes its products to Peru, Bolivia, Chile, Argentina, Paraguay, Brazil, Venezuela, Central America and the United States.

Headquarters
Cl 79B Cr 78C 21
Barranquilla; Atlantico;

Contact Details: Purchase the C.I. Farmacapsulas S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the C.I. Farmacapsulas S.A.S. report to view the information.
Outstanding Shares:
Purchase the C.I. Farmacapsulas S.A.S. report to view the information.
Registered Capital:
Purchase the C.I. Farmacapsulas S.A.S. report to view the information.
Incorporation Date:
May 05, 1975
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Company Performance
Financial values in the chart are available after C.I. Farmacapsulas S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
44.46%▲
Total operating revenue
44.59%▲
Operating profit (EBIT)
57.31%▲
EBITDA
48.69%▲
Net Profit (Loss) for the Period
14.33%▲
Total assets
36.56%▲
Total equity
-2.96%▼
Operating Profit Margin (ROS)
0.98%▲
Net Profit Margin
-1.33%▼
Return on Equity (ROE)
1.87%▲
Debt to Equity Ratio
29.61%▲
Quick Ratio
-0.22%▼
Cash Ratio
0.02%▲

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo